consumer_health

German Sugary Soft Drink Output Falls 4.1% to 7.42bn Liters

Wiesbaden – November 03, 2026 -- German producers made 7.42 billion liters of sugary soft drinks in 2025, 4.1% less than the almost 7.74 billion liters of 2024, according to the Federal Statistical Office (Destatis). Output of calorie-reduced light drinks and mineral water rose over the same period, as the federal government plans to introduce a levy on sugary beverages.

Light cola and lemonade output rises 5.1% to 1.61 billion liters

Producers made 1.61 billion liters of calorie-reduced cola and lemonade in 2025, up from 1.53 billion liters in 2024. Per capita production of light drinks rose from just over 18 liters to just over 19 liters. Sugary drinks still clearly outweigh light products by volume. Per capita output of sugary drinks fell from almost 93 liters to about 89 liters.

The sugary category covers regular cola, lemonade, fruit spritzers, flavored waters, vitamin and energy drinks and other soft drinks such as fizzy sodas.

Opella Study Links Cough Treatment to 55-59% Fewer Sleep Issues

Image
Opella Study Links Cough Treatment to 55-59% Fewer Sleep Issues

Paris – October 15, 2026 -- The share of patients reporting sleep difficulties fell by 59%, 56% and 55% within 48 hours of starting Mucosolvan or Bisolvon, according to a new real-world study from Opella on acute chesty cough.

Sleep complaints drop across three categories within 48 hours

The percentage of patients reporting difficulty falling asleep fell by 59%. Those reporting difficulty staying asleep fell by 56%, and those reporting sleep-related tiredness by 55%. Opella describes sleep disruption as a primary patient concern.

Social impact of cough improves meaningfully within 72 hours

Patients achieved a clinically meaningful improvement in the social impact of cough within 72 hours. Data also showed improvements in daily functioning from the first day of treatment.

Monteloeder's Elissara Shows Preclinical Hair-Growth Activity in New Study

Image
Monteloeder's Elissara Shows Preclinical Hair-Growth Activity in New Study

Madrid – September 06, 2026 -- Monteloeder, SL, a subsidiary of SuanNutra, SA, has published preclinical data showing its nutricosmetic ingredient Elissara® increases human dermal papilla cell proliferation to roughly 2.5 times that of untreated controls, extending the compound's known scalp benefits into follicular biology.